Home | Brain and Nerves | Brain Diseases

Brain Diseases

Levodopa-Carbidopa Intestinal Gel May Prove More Effective for Long-Term Treatment of Parkinson’s Disease than Standard Levodopa

Report in the Journal of Parkinson’s Disease presents data from one-year trial on long-term safety, efficacy, and quality of life in advanced ...

Parkinson’s Disease Patients Have Reduced Visual Contrast Acuity

Researchers Have Developed an iPad® Application that Can Help Physicians Screen for this Condition, as Reported in a New Study in the ...

New molecule could slow the progression of Parkinson’s

Our researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease. ... Full story

People with Multiple Sclerosis May Have Lower Levels of Key Nutrients

WASHINGTON, DC – Women with multiple sclerosis (MS) may have lower levels of important antioxidant and anti-inflammatory nutrients, such as folate from food and vitamin E, than healthy people, according to a new study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015. ... Full story

Stanley Center at the Broad Institute and New York Stem Cell Foundation partner to develop stem cell resource for schizophrenia and psychiatric diseases

Induced pluripotent stem cell lines to be made from people with schizophrenia and other psychiatric disorders, to study cell changes ... Full story

New growth factor indicates possible regenerative effects in Parkinson's disease

Researchers have long sought treatments that can slow the progression of Parkinson's disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopamine, which the dying nerve cells can no longer produce. Results from a recent clinical study offer hope that future therapies could take advantage of the brain's own protective mechanisms to limit neuronal cell death and restore dopamine production to natural levels. ... Full story

New therapeutic principle for Parkinsonian dyskinesia shows clinical effect

Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson’s disease. Now, however, researchers at Karolinska Institutet and Lund University in Sweden seem to be close to a novel therapy to this distressing side effect. ... Full story

Multiple sclerosis: pathological progression of the disease documented for the first time - possible new treatment options

(Vienna) The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play. ... Full story

Halting Huntington's disease

In a world-first, Edith Cowan University (ECU) researchers have found a way to repair parts of the brain affected by Huntington’s disease. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 288 | displaying: 1 - 10